AU2002333626B2 - 1-glyoxlylamide indolizines for treating cancer - Google Patents

1-glyoxlylamide indolizines for treating cancer Download PDF

Info

Publication number
AU2002333626B2
AU2002333626B2 AU2002333626A AU2002333626A AU2002333626B2 AU 2002333626 B2 AU2002333626 B2 AU 2002333626B2 AU 2002333626 A AU2002333626 A AU 2002333626A AU 2002333626 A AU2002333626 A AU 2002333626A AU 2002333626 B2 AU2002333626 B2 AU 2002333626B2
Authority
AU
Australia
Prior art keywords
substituted
group
unsubstituted
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002333626A
Other languages
English (en)
Other versions
AU2002333626A1 (en
Inventor
Keizo Koya
Hao Li
Mitsunori Ono
Lijun Sun
Weiwen Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synta Phamaceuticals Corp
Original Assignee
Synta Phamaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Phamaceuticals Corp filed Critical Synta Phamaceuticals Corp
Publication of AU2002333626A1 publication Critical patent/AU2002333626A1/en
Application granted granted Critical
Publication of AU2002333626B2 publication Critical patent/AU2002333626B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002333626A 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer Ceased AU2002333626B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
US60/322,020 2001-09-13
PCT/US2002/029154 WO2003022846A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Publications (2)

Publication Number Publication Date
AU2002333626A1 AU2002333626A1 (en) 2003-06-19
AU2002333626B2 true AU2002333626B2 (en) 2006-06-29

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002333626A Ceased AU2002333626B2 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Country Status (19)

Country Link
US (2) US6861436B2 (enExample)
EP (1) EP1432709B8 (enExample)
JP (1) JP2005504795A (enExample)
KR (1) KR20040053125A (enExample)
CN (1) CN1568324A (enExample)
AT (1) ATE300542T1 (enExample)
AU (1) AU2002333626B2 (enExample)
BR (1) BR0212794A (enExample)
CA (1) CA2459886A1 (enExample)
DE (1) DE60205265T2 (enExample)
ES (1) ES2245747T3 (enExample)
IL (1) IL160810A0 (enExample)
IS (1) IS7176A (enExample)
MX (1) MXPA04002323A (enExample)
NO (1) NO20041035L (enExample)
NZ (1) NZ531700A (enExample)
PT (1) PT1432709E (enExample)
WO (1) WO2003022846A1 (enExample)
ZA (1) ZA200401996B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
JP2006504692A (ja) * 2002-09-13 2006-02-09 シンタ ファーマシューティカルズ コーポレーション インドリジンの合成方法
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
US20070293456A9 (en) * 2004-12-30 2007-12-20 Anthony Hayford Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
WO2006128184A2 (en) * 2005-05-20 2006-11-30 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
CA2733247C (en) * 2008-08-14 2018-04-03 Beta Pharma Canada Inc. Heterocyclic amide derivatives as ep4 receptor antagonists
EP4008327A1 (en) 2009-04-29 2022-06-08 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) * 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
US6472389B1 (en) 1998-05-21 2002-10-29 Shionogi & Co., Ltd. Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
CA2346334A1 (en) 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Composition for treating or preventing ischemia reperfusion injury
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Also Published As

Publication number Publication date
IL160810A0 (en) 2004-08-31
CA2459886A1 (en) 2003-03-20
NO20041035L (no) 2004-04-30
DE60205265T2 (de) 2006-03-30
KR20040053125A (ko) 2004-06-23
ZA200401996B (en) 2005-05-31
MXPA04002323A (es) 2005-04-08
EP1432709B1 (en) 2005-07-27
EP1432709A1 (en) 2004-06-30
US6861436B2 (en) 2005-03-01
JP2005504795A (ja) 2005-02-17
EP1432709B8 (en) 2005-11-02
IS7176A (is) 2004-03-11
ES2245747T3 (es) 2006-01-16
WO2003022846A1 (en) 2003-03-20
HK1063322A1 (en) 2004-12-24
DE60205265D1 (de) 2005-09-01
PT1432709E (pt) 2005-10-31
BR0212794A (pt) 2004-10-05
CN1568324A (zh) 2005-01-19
ATE300542T1 (de) 2005-08-15
US20030153759A1 (en) 2003-08-14
NZ531700A (en) 2006-10-27
US20040214850A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
AU2002323475B2 (en) 2-aroylimidazole compounds for treating cancer
AU2002333626B2 (en) 1-glyoxlylamide indolizines for treating cancer
JP2018524365A (ja) Ｉｒａｋ−４阻害剤としての置換アザ化合物
KR20150123894A (ko) 히스톤 데메틸라아제의 저해제
JP4429607B2 (ja) 新規ピリジルシアノグアニジン化合物
RU2195453C2 (ru) Цианогуанидины, способы их получения и фармацевтический препарат на их основе
AU2002323474B2 (en) 3-glyoxlylamideindoles for treating cancer
AU2002333626A1 (en) 1-glyoxlylamide indolizines for treating cancer
JP2020502066A (ja) キナーゼ阻害剤としての複素環式化合物
AU2002323474A1 (en) 3-glyoxlylamideindoles for treating cancer
JP2016508521A (ja) 抗腫瘍剤としての三環式複素環
JP4349476B2 (ja) 細胞増殖抑制剤としてのシアノグアニジン
KR20010013158A (ko) 세포 증식 억제제로서의 시아노구아니딘
RU2195451C2 (ru) Цианогуанидины, способы их получения и фармацевтический препарат на их основе
EP1598352A1 (en) 1-Glyoxylamide indolizines for treating cancer
HK1063322B (en) 1-glyoxylamide indolizines for treating cancer
HK1079507A (en) 1-glyoxylamide indolizines for treating cancer
WO2023168908A1 (zh) 稠合的醌肟咪唑及其鎓衍生物与其制备和用途
JP2021517160A (ja) Ｆｍｓ様チロシンキナーゼ阻害剤
TW202408991A (zh) Ido/tdo抑制劑
KR20250097910A (ko) 포스파티딜이노시톨 3-키나제의 신규 억제제

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired